ADIPONECTIN DEFICIENCY EXACERBATES WHILE ADIPORON ATTENUATES TAUOPATHY IN MICE WITH HUMAN TAU MUTATION
Division of Neurology, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Presentation
Date TBA
Event Information
Poster Board
PS04-08PM-060
Poster
View posterAbstract
Methods: Cognitive functions of 9-month-old wildtype, APN knockout (APN-/-) mice, human tau P301S mutation transgenic (TauP301S) mice, and APN-deficient tau (TauP301S; APN-/-) mice were examined by novel object recognition (NOR) test. Brain pathologies were analysed by immunofluorescent staining. Single-nucleus RNA sequencing was performed to examine APN-mediated transcriptomic alterations in the brains. The therapeutic effects of adipoRon were assessed by treating 6-month-old TauP301S; APN-/- mice for three months.
Results: TauP301S; APN-/- mice spent less time exploring the novel object than wildtype during the NOR test. The immunoreactivity of hyperphosphorylated tau (AT8) and microglia marker ionized calcium-binding adaptor molecule 1 (Ibal) were elevated in TauP301S; APN-/- mice. TauP301S; APN-/- mice exhibited reduced neuronal nuclei (NeuN) positive neurons and spinophilin positive synapses. Single-nucleus RNA sequencing revealed upregulated microglia-mediated immune response in TauP301S; APN-/- mice compared with TauP301S mice. Chronic adipoRon treatment improved cognitive functions, reduced AT8 and Iba1 immunoreactivity, and enhanced NeuN and spinophilin staining intensity in TauP301S; APN-/- mice compared with vehicle treatment. Conclusion: APN deficiency aggravates cognitive impairments and neuropathologies, which are reversed by adipoRon treatment.
Recommended posters
ADIPONECTIN SIGNALING PRESERVES BLOOD–BRAIN BARRIER INTEGRITY AND COGNITIVE FUNCTION IN CHRONIC HYPOPERFUSION–INDUCED VASCULAR COGNITIVE IMPAIRMENT
Hongjian Pu, Junxuan Lyu, Wenting Zhang, Jiajing Shan, Fei Xu, Rehana K Leak, R. Anne Stetler, Xiaoming Hu, Jun Chen
TARGETING MICROGLIA TO MITIGATE TAU PATHOLOGY AND COGNITIVE DEFICITS IN A DOUBLE-TRANSGENIC APP-TAU MOUSE MODEL
Yixia Jin, Uxía Fraga-Bouzas, Irene Pallás, Carlos A. Saura, Mar Puigdellívol
TELOMERE-INDUCED BRAIN SENESCENCE LOWERS AMYLOID BURDEN IN HUMANIZED APP-SAA KNOCK-IN MICE WHILE PROMOTING TAU PATHOLOGY AND NEURODEGENERATION IN PS19 TAUOPATHY MICE
Nuria Suelves Caballol, Debora Palomares, Pascal Kienlen-Campard
P75 NEUROTROPHIN RECEPTOR SIGNALING THROUGH THE RHOA/ROCK PATHWAY CONTRIBUTES TO ALZHEIMER’S DISEASE TAUOPATHY
Liao Kang, Meng Xie, Carlos Ibanez
DEVELOPMENT OF AN IN-VIVO MODEL OF TAUOPATHY THROUGH INTRA-HIPPOCAMPAL INJECTION OF HUMAN TAU PRE-FORMED FIBRILS INTO THE BRAINS OF AGED MICE
Georgia Culley, Grace Flower, Adrien Chabert, Alexis Heesen, Ludovic Ainardi, Carla Rocci, Alexandre Wojcinski, Alexandre Henriques, Noelle Callizot
DYRK1A INHIBITION WITH THE NOVEL THERAPEUTIC, DYR533, IN THE PS19 MOUSE MODEL OF TAUOPATHY ATTENUATES TAU PATHOLOGY, NEUROINFLAMMATION, AND SYNAPTIC FUNCTION
Samantha Bartholomew, Wendy Winslow, Nathaniel Hansen, Melissa Martinez, Ritin Sharma, Christopher Hulme, Travis Dunckley, Patrick Pirotte, Ramon Velazquez